DGFT Minutes
In force — no superseding record on file.
Government of India Ministry of CommerceandIndustry Department of Commerce DIRECTORATE GENERAL OF FOREIGN TRADE
MINUTES OF MEETING OF PERSONAL HEARING
Minutes of the Norms Committee –3 Meeting No.NC/3/MEET/Nov/202324/16 dated 09/11/2023 under the Chairmanship of Shri Rajiv Kumar Soni, Jt. DGFT for considering the cases/issues under Duty Exemption Scheme (Chapter-4) of Foreign Trade Policy, 2023 pertaining to Chemical and Allied products falling under Chapter 29 and 30.
Following members were present in the Meeting:
| S.N.<br>Name & Designation<br>Department | S.N.<br>Name & Designation<br>Department | S.N.<br>Name & Designation<br>Department |
|---|---|---|
| 1<br>Shri Shaish Kumar, Technical<br>Consultant (Pharma) | ||
| 2<br>Shri D.N. Mathur, Technical<br>Consultant (Chemical) | ||
| 3<br>Shri Nand Lal, Technical<br>Consultant (Chemical) | ||
| In attendance | ||
| 1 | Shri T. Songzalian, Deputy DGFT | DGFT |
- The Norms Committee has taken decision only with respect to technical aspect/ wastage norms. While redeeming the application, RAs should check that the applicant has fulfilled all requirements as prescribed in policy/procedure including those in policy circulars issued from time to time or any other provisions under FTP/HBP for issuance of Advance Authorization and regularization of the case.
Manual Cases of Personal Hearing
| Manual Cases of Personal Hearing | Manual Cases of Personal Hearing | Manual Cases of Personal Hearing | |
|---|---|---|---|
| CaseNo.<br>**A-1 ** | |||
| MeetingNo.<br>NC/3/MEET/Nov/202324/16 | |||
| Date<br>09/11/2023 | |||
| Firm’sName<br>M/s Aurore Life Sciences Private Limited | |||
| <br> | |||
| HQ F. No.<br>HQRNORMREVIW00004138/AM23/DES-III<br>liF////A/DESIII | |||
| (Earer. No. 018205001774M21-) | |||
| RLA F No | 09/24/040/00365/AM21 | ||
| . . | |||
| AdvanceAuth | orization No.andDate<br>0910069368 dated 22.10.2020. | ||
| Subject | Request of M/s Aurore Life Sciences Private Limitedfor | ||
| enhancement of import item in advance authorization<br>issued to the firm. | |||
| **Decision:**Dr.<br> | S. Suresh Babu (RnD Head) and Shri Sumeet Asthana, (GM-Commercial)of the firm had<br> | ||
| attended the Pe<br>of the firm and | rsonal Hearing and explained the case. The Committee heard the explanation of Representative<br>after due deliberation the committee has considered the request of the firm on the basis of | ||
| <br>information pro | <br>vided by the firm and it was decided to refer the case to the TE for comments. | ||
| CaseNo.<br>**A-2 **<br>MeetingNo.<br>NC/3/MEET/Nov/202324/16<br>Date<br>09/11/2023<br>Firm’sName<br>M/s Inchem Laboratories Private Limited<br>HQ F. No.<br>HQRNORMREVIW00004198/AM24/DES-III<br>(EarlierF.No. 01/82/050/01493/AM12 /DES-III)<br>HQRNORMAPPLY00261092AM22 |
/2023<br>Firm’sName<br>M/s Inchem Laboratories Private Limited<br>HQ F. No.<br>HQRNORMREVIW00004198/AM24/DES-III<br>(EarlierF.No. 01/82/050/01493/AM12 /DES-III)<br>HQRNORMAPPLY00261092AM22||||
| CaseNo.<br>**A-2 ** | CaseNo.<br>**A-2 ** | CaseNo.<br>**A-2 ** | |
|---|---|---|---|
| MeetingNo.<br>NC/3/MEET/Nov/202324/16 | |||
| Date<br>09/11/2023 | |||
| Firm’sName<br>M/s Inchem Laboratories Private Limited | |||
| HQ F. No.<br>HQRNORMREVIW00004198/AM24/DES-III<br>(EarlierF.No. 01/82/050/01493/AM12 /DES-III)<br>HQRNORMAPPLY00261092AM22 | |||
| RLA F. No.<br>09/24/040/00579/AM12<br> | |||
| 09/AA/040/16734/AM22 | |||
| <br>0910051360 dd 21022012 | |||
| Advance Aut | orization No. and Date<br>ate ..<br>0911001888 dated 22.11.2021. | ||
| Subject | Request of M/s Inchem Laboratories Private Limited for | ||
| enhancement of import item in Advance Authorisation<br>issued to the firm. | |||
| **Decision:**The<br> | Committee considered the request of firm for review of ad-hoc norms and it was observed<br> | ||
| that the firm h<br>torejectthe ca | ad neither attended the Personal Hearing nor intimated to committee. Hence, it was decided<br>se maintainin thestatus quo | ||
| g**.** | |||
| Case No.<br>A-3<br>MeetingNo.<br>NC/3/MEET/Nov/202324/16<br>Date<br>09/11/2023<br>Firm’sName<br>M/s Inchem Laboratories Private Limited<br>HQ F. No.<br>HQRNORMREVIW00004198/AM24/DES-III<br>(EarlierF. No. 01/82/050/01493/AM12 /DES-III)<br>RLA F.No.<br>09/24/040/00579/AM12<br>Advance Authorization No. and Date<br>0910051360 dated 21.02.2012 |
HQRNORMREVIW00004198/AM24/DES-III<br>(EarlierF. No. 01/82/050/01493/AM12 /DES-III)<br>RLA F.No.<br>09/24/040/00579/AM12<br>Advance Authorization No. and Date<br>0910051360 dated 21.02.2012||||
| Case No.<br>A-3 | Case No.<br>A-3 | Case No.<br>A-3 | |
|---|---|---|---|
| MeetingNo.<br>NC/3/MEET/Nov/202324/16 | |||
| Date<br>09/11/2023 | |||
| Firm’sName<br>M/s Inchem Laboratories Private Limited | |||
| HQ F. No.<br>HQRNORMREVIW00004198/AM24/DES-III<br>(EarlierF. No. 01/82/050/01493/AM12 /DES-III) | |||
| RLA F.No.<br>09/24/040/00579/AM12 | |||
| Advance Authorization No. and Date<br>0910051360 dated 21.02.2012 | |||
| Subject<br>Request of M/s Inchem Laboratories Private Limited for | |||
| <br>enhancement of import items against the Advance<br> | |||
| Authorisation issued to the firm. | |||
| **Decision:**The<br>h h fi h | Committee considered the request of firm for review of ad-hoc norms and it was observed<br>d ih dd h l i iid i i didd | ||
| tat te rm<br>torejectthe ca | neter attene te Persona Hearng nor ntmate to commttee. Hence, t was ece<br>se maintaining thestatus quo. | ||
==> picture [461 x 228] intentionally omitted <==
rm<br>torejectthe ca|neter attene te Persona Hearng nor ntmate to commttee. Hence, t was ece<br>se maintaining thestatus quo.|| |||||
==> picture [461 x 228] intentionally omitted <==
----- Start of picture text -----<br> Case No. A-4<br>Meeting No. NC/3/MEET/Nov/202324/16<br>Date 09/11/2023<br>Firm’s Name M/s Novel Nutrients Private Limited<br>HQ F. No. HQRNORMREVIW00001058/AM24/DES-III<br> (Earlier F. No 01/82/050/01324/AM17/DES-III)<br>F. No. HQRNORMREVIW00001063/AM24/DES-III<br>(Earlier F. No 01/82/050/00262/AM20/DES-III)<br>RLA F. No. 07/24/040/00056/AM20<br>07/24/040/00038/AM21<br>Advance Authorization No. and Date 0710116503 dated 26.05.2020<br>0710115041 dated 11.06.2019<br>Subject Request of M/s Novel Nutrients Private Limitedfor<br>enhancement ofimport items in Advance Authorisation<br>issued to the firm.<br>Decision: The committee considered the case as per agenda and it was observed that the firm vide e-mail<br>dated 03/11/2023 has informed that they have surrendered the licenses. Therefore, the committee decided<br>to withdraw the applications of the firm.<br>----- End of picture text -----<br>
==> picture [461 x 264] intentionally omitted <==
dered the licenses. Therefore, the committee decided<br>to withdraw the applications of the firm.<br>----- End of picture text -----<br>
==> picture [461 x 264] intentionally omitted <==
----- Start of picture text -----<br> Case No. A-5<br>Meeting No. NC/3/MEET/Nov/202324/16<br>Date 09/11/2023<br>Firm’s Name M/s Clariant India Limited<br>HQ F. No. HQRNORMREVIW00004498/AM24/DES-III<br>(Earlier F. No. HQRNORMAPPLY00032203/AM22 /DES-III)<br>F. No. HQRNORMREVIW00004497/AM24/DES-III<br>(Earlier F. No. HQRNORMAPPLY00302256/AM22 /DES-III)<br>HQRNORMREVIW00004661/AM24/DES-III<br>(Earlier F. No. HQRNORMAPPLY00006061/AM23 /DES-III)<br>018205001343AM21<br>RLA F. No. 03/AA/040/09823/AM22<br>03/AX/040/00499/AM22<br>03/AX/040/05405/AM23<br>039404000110AM21<br>Advance Authorization No. and Date 0311003530 dated 04.05.2021<br>0311009919 dated 30.12.2021<br>0310836469 dated 01.06.2020<br>0311021129 dated 03.02.2023<br>Subject Request of M/s Clariant India Limited for enhancement of<br>import items in Advance Authorisation issued to the firm.<br>----- End of picture text -----<br>
Decision: Ms. Meghana Abhijit Karpe, Logistic Head and Shri Prashant Wadaskar, Plant Manager of the firm had attended the Personal Hearing and explained the case. The Committee heard the explanation of Representative of the firm and after due deliberation the committee has considered for review of ad-hoc norms on the basis of information provided by the firm, it was decided to revise ad-hoc norms as under, or as applied whichever is lower: -
eration the committee has considered for review of ad-hoc norms on the basis of information provided by the firm, it was decided to revise ad-hoc norms as under, or as applied whichever is lower: -
| Export Product | Qty. | Sl.<br>No. | Import Items | Qty. allowed. |
|---|---|---|---|---|
| PIROCTONE<br>OLAMINE<br>OR<br>VIPIROX<br>(Octopirox plus) | 1 kg. | 1 | Dimethyl acrylic acid ester | 0.84 kg. |
| 2 | Hydroxyl amine hydrochloride | 1.54 kg. | ||
| 3 | Isononyl acid chloride | 1.667 kg. |
RA concerned may take further necessary action as per above decision of NC.
| Case No.<br> | A-6 |
| MeetingNo. | NC/3/MEET/Nov/202324/16 |
| Date | 09/11/2023 |
| Firm’s Name | M/s Synokem Pharmaceuticals Limited |
| HQF. No. | HQRNORMAPPLY00147457AM22 |
| RLA F. No. | 05/AA/040/59070/AM22 |
| Advance Authorization No. and Date | 0511003826 dated 26.07.2021 |
| Subject | Request of M/s Synokem Pharmaceuticals Limited for fixation<br>of ad-hoc norms against Advance Authorisation issued to the<br>firm. |
| **Decision:**Shri Krishan Khemka, Consultant and Shri Deepak Nagar, Manager ofthe firm had attended the | |
| Personal Hearing and explained the case. The Committee heard the explanation of Representative of the firm | |
| and after due deliberation the committee has advised to the firm to amend the license from concerned RA with | |
| correct export product and import item. |
planation of Representative of the firm|| |and after due deliberation the committee has advised to the firm to amend the license from concerned RA with|| |correct export product and import item.||
| Case No.<br> A-7 | |
|---|---|
| MeetingNo.<br>NC/3/MEET/Nov/202324/16 | |
| Date<br>09/11/2023 | |
| Firm’s Name<br>M/s Best Value Chem Private Limited | |
| HQ F. No.<br>HQRNORMREVIW00006174/AM23/DES-III<br>(EarlierF.No. HQRNORMAPPLY00164145/AM22/DES-III) | |
| RLA F. No.<br>34/AA/040/06527/AM22 | |
| Advance Authorization No. and Date<br>3411000984 dated 17.08.2021 | |
| Subject<br>Request of M/s Best Value Chem Private Limited for<br>enhancement of quantity of import item against the Advance<br>Authorisation issued to the firm. | |
| **Decision:**Dr. Dhaval Patel, Technical Expert, Shri Dhruval Parmar (Exim)of the firm had attended the | |
| Personal Hearing and explained the case. The Committee heard the explanation of Representative of the | |
| firm and after due deliberation the committee has considered for review of ad-hoc norms on the basis of | |
| information provided by the firm, it was decided to revise ad-hoc norms as under, or as applied whichever is | |
| less: - | |
| Export Product<br>Qty.<br>Sl.<br>No.<br>Import Items<br>Qty. allowed. | |
| Limbunile(3,7-Dimethyl-2(3),<br>1 kg.<br>1<br>Ethyl Heptenone<br>1.145 kg. | |
| 6-nonadienonitrile))<br>2<br>Cyano Acetic acid (70%)<br>1.75 kg. | |
| **Note: The above norms are for regularization and closure purpose only. |
hyl-2(3),<br>1 kg.<br>1<br>Ethyl Heptenone<br>1.145 kg.|| |6-nonadienonitrile))<br>2<br>Cyano Acetic acid (70%)<br>1.75 kg.|| |Note: The above norms are for regularization and closure purpose only. No repeat Licence|| |may be allowed by RA on above norms.|| |RA concerned may take further necessary action as per above decision of NC.||
| Case No. | A-8 |
|---|---|
| MeetingNo. | NC/3/MEET/Nov/202324/16 |
| Date | 09/11/2023 |
| Firm’s Name | M/s Best Value Chem Private Limited |
| HQF. No. | HQRNORMAPPLY00195372AM22/DES-III |
| RLA F. No. | 34/AA/040/06808/AM22 |
| Advance Authorization No. and Date | 3411001180 dated 27.09.2021 |
| Subject | Request of M/s Best Value Chem Private Limited for fixation<br>of ad-hoc norms against Advance authorization issued to the<br>firm. |
| **Decision:**Dr. Dhaval Patel, Technical Expert, Shri Dhruval Parmar (Exim)of the firm had attended the | |
| Personal Hearing and explained the case. | The Committee heard the explanation of Representative of the |
| firm and after due deliberation the committee has considered for review of ad-hoc norms on the basis of | |
| informationprovided bythe firm,it was decided to revise ad-hoc norms as under,or as applied whichever is |
less: -
| s: - | ||||
|---|---|---|---|---|
| Export Product | Qty. | Sl.<br>No. | Import Items | Qty.<br>allowed. |
| POMELO ACETAL<br>(6,6-Dimethoxy-2,5,5-trimethylhex- 2-ene) | 1 kg. | 1 | 2-Methyl-3-butene-2- ol | 0.616 kg. |
| 2 | Tri Methyl Ortho formate | 0.71 kg. | ||
| 3 | Iso Butyraldehyde | 1.105 kg. |
**<br>allowed.| |POMELO ACETAL<br>(6,6-Dimethoxy-2,5,5-trimethylhex- 2-ene)|1 kg.|1|2-Methyl-3-butene-2- ol|0.616 kg.| |||2|Tri Methyl Ortho formate|0.71 kg.| |||3|Iso Butyraldehyde|1.105 kg.|
Note: The above norms are for regularization and closure purpose only. No repeat Licence may be allowed by RA on above norms.
RA concerned may take further necessary action as per above decision of NC.
| Case No.<br> **A-9 ** | ||
|---|---|---|
| MeetingNo.<br>NC/3/MEET/Nov/202324/16 | ||
| Date<br>09/11/2023 | ||
| Firm’s Name<br>M/s Best Value Chem Private Limited | ||
| HQF. No.<br>HQRNORMAPPLY00289566AM22 | ||
| RLA F. No.<br>34/AX/040/00036/AM22 | ||
| Advance Authorization No. and Date<br>3411001553 dated 17.12.2021 | ||
| Subject<br>Request of M/s Best Value Chem Private Limited for fixation<br>of ad-hoc norms against Advance authorization issued to the<br>firm. | <br> | |
| **Decision:**Dr. Dhaval Patel, Technical Expert, Shri Dhruval Parmar (Exim)of the firm had attended the | ||
| Personal Hearing and explained the case. The Committee heard the explanation of Representative of the firm | ||
| and after due deliberation the committee has considered for review of ad-hoc norms on the basis of | ||
| information provided by the firm, it was decided to revise ad-hoc norms as under, or as applied whichever is | ||
| less: - | ||
| Export Product<br>Qty.<br>Sl.<br>No.<br>Import Items | Qty.<br>allowed. | |
| PHENOXYETHYL<br>ISOBUTYRATE<br>1 kg. |
oc norms as under, or as applied whichever is||| |less: -||| |Export Product<br>Qty.<br>Sl.<br>No.<br>Import Items|Qty.<br>allowed.|| |PHENOXYETHYL<br>ISOBUTYRATE<br>1 kg. 1<br>ISOBUTYRIC ACID|0.5633 kg.|| |(Phenoxy)ethyl 2-methylpropanoate)||| |Note: The above norms are for regularization and closure purpose only. No repeat Licence||| |may be allowed by RA on above norms.||| |RA concerned maytake further necessaryaction asper above decision of NC.|||
| Case No.<br> | A-10 | ||
|---|---|---|---|
| MeetingNo. | NC/3/MEET/Nov/202324/16 | ||
| Date | 09/11/2023 | ||
| Firm’s Name | M/s Best Value Chem Private Limited | ||
| HQF. No. | HQRNORMAPPLY00289569AM22 | ||
| RLA F. No. | 34/AX/040/00035/AM22 | ||
| Advance Authorization No. and Date | 3411001554 dated 17.12.2021 | ||
| Subject | Request of M/s Best Value Chem Private Limited for fixation of<br>ad-hoc norms against Advance authorization issued to the firm. | ||
| **Decision:**Dr. Dhaval Patel, Technical Expert, Shri Dhruval Parmar (Exim)of the | firm had attended the | ||
| Personal Hearing and explained the case. | The Committee heard the explanation of | Representative of the | |
| firm and after due deliberation the committee has considered for review of ad-hoc norms on the basis of | |||
| information provided by the firm, it was decided to revise ad-hoc norms as under, or as applied whichever is | |||
| less: - | |||
| Export Product | **Qty. **<br>Sl. No.<br>Import Items | **Qty. |
|information provided by the firm, it was decided to revise ad-hoc norms as under, or as applied whichever is|||| |less: -|||| |Export Product|**Qty. **<br>Sl. No.<br>Import Items|Qty. allowed.|| |EM PENTANOATE|1 kg.<br>1<br>Propionaldehyde|1.20 kg.|| |(ETHYL-2-METHYL PENTANOATE)|||| |Note: The above norms are for regularization and closure purpose only. No repeat Licence||||
may be allowed by RA on above norms.
RA concerned may take further necessary action as per above decision of NC.
| Case No.<br>A-11 | |
|---|---|
| MeetingNo.<br>NC/3/MEET/Nov/202324/16 | |
| Date<br>09/11/2023 | |
| Firm’s Name<br>M/s Best Value Chem Private Limited | |
| HQ F. No.<br>HQRNORMREVIW00007005/AM23/DES-III<br>(EarlierF.No. HQRNORMAPPLY00343056/AM22/DES-III) | |
| RLA F. No.<br>34AX04000212AM22 | |
| Advance Authorization No. and Date<br>3411001750 dated 04.02.2022 | |
| Subject<br>Request of M/s Best Value Chem Private Limited for enhancement in<br>the quantity of import item No. 3 - Magnesium Turning in respect of<br>ad-hoc norms fixed against Advance Authorization No. 3411001750<br>dated 04.02.2022. | |
| **Decision:**Dr. Dhaval Patel, Technical Expert, Shri Dhruval Parmar (Exim)of the firm had attended the | |
| Personal Hearing and explained the case. The Committee heard the explanation of Representative of the firm | |
| and after due deliberation the committee has considered for review of ad-hoc norms on the basis of | |
| information provided by the firm, it was decided to revise ad-hoc norms as under, or as applied whichever is | |
| less: - | |
| Export Product<br>**Qty. **<br>Sl. No.<br>Import Items<br>Qty. allowed. | |
| Undecavertol (Kakdinol)<br>1 kg.<br>1<br>Propionaldehyde<br>0.947 kg. | |
| (4-Methyl-3-decen- 5-ol))<br>2<br>1-Pentanol / N Amyl Alcohol<br>0.709 kg. | |
| 3<br>Magnesium Turning<br>0.182 kg. | |
| **Note: The above norms are for regularization and closure purpose only. |
47 kg.|| |(4-Methyl-3-decen- 5-ol))<br>2<br>1-Pentanol / N Amyl Alcohol<br>0.709 kg.|| |3<br>Magnesium Turning<br>0.182 kg.|| |Note: The above norms are for regularization and closure purpose only. No repeat Licence|| |may be allowed by RA on above norms.|| |RA concerned may take further necessary action as per above decision of NC.||
==> picture [462 x 277] intentionally omitted <==
----- Start of picture text -----<br> Case No. A-12<br>Meeting No. NC/3/MEET/Nov/202324/16<br>Date 09/11/2023<br>Firm’s Name M/s Best Value Chem Private Limited<br>HQ F. No. HQRNORMAPPLY00001745AM23<br>RLA F. No. 34/AX/040/00259/AM23<br>Advance Authorization No. and Date 3411002449 dated 29.06.2022<br>Subject Request of M/s Best Value Chem Private Limited for<br>fixation of ad-hoc norms against Advance Authorisation<br>issued to the firm.<br>Decision: Dr. Dhaval Patel, Technical Expert, Shri Dhruval Parmar (Exim) of the firm had attended the<br>Personal Hearing and explained the case. The Committee heard the explanation of Representative of the firm<br>and after due deliberation the committee has considered for review of ad-hoc norms on the basis of<br>information provided by the firm, it was decided to revise ad-hoc norms as under, or as applied whichever is<br>less: -<br>Export Product Qty. Sl. No. Import Items Qty. allowed.<br>Undecavertol (Kakdinol) 1 kg.
ided by the firm, it was decided to revise ad-hoc norms as under, or as applied whichever is<br>less: -<br>Export Product Qty. Sl. No. Import Items Qty. allowed.<br>Undecavertol (Kakdinol) 1 kg. 1 Propionaldehyde 0.947 kg.<br>(4-Methyl-3-decen- 5-ol)) 2 1-Pentanol / N Amyl Alcohol 0.709 kg.<br>3 Magnesium Turning 0.182 kg.<br>Note: The above norms are for regularization and closure purpose only. No repeat Licence<br>----- End of picture text -----<br>
may be allowed by RA on above norms.
RA concerned may take further necessary action as per above decision of NC.
| Case No.<br> | A-13 | |||
|---|---|---|---|---|
| MeetingNo. | NC/3/MEET/Nov/202324/16 | |||
| Date | 09/11/2023 | |||
| Firm’s Name | M/s Best Value Chem Private Limited | |||
| HQ F. No. | HQRNORMREVIW00005934/AM23/DES-III<br>(EarlierF. No. HQRNORMAPPLY00001795/AM23/DES-III) | |||
| RLA F. No. | 34/AX/040/00311/AM23 | |||
| Advance Authorization No. and Date | 3411002472 dated 01.07.2022 | |||
| Subject | Request of M/s Best Value Chem Private Limited for<br>enhancement in the quantity of import item in respect of ad-<br>hoc norms fixed against Advance Authorization No.<br>3411002472 dated 01.07.2022. | |||
| **Decision:**Dr. Dhaval Patel, Technical Expert, Shri Dhruval Parmar (Exim)of the firm had attended the | ||||
| Personal Hearing and explained the case. | The Committee heard the explanation of Representative of the | |||
| firm and after due deliberation the committee has considered for review of ad-hoc norms on the basis of | ||||
| information provided by the firm, it was decided to revise ad-hoc norms as under, or as applied | whichever is | |||
| less: - | ||||
| Export Product | Qty.<br>Sl.<br>No.<br>Import Items | Qty.<br>allowed. | ||
| MELONAL | 1 kg.<br>1<br>Methyl Heptenone | 1.50 kg. | ||
| (2,6-dimethylhept-5-enal)<br>(Clear colorless liquid) | 2<br>Methyl Mono Chloro Acetate/<br>Ethyl Chloro Acetate | 1.72 kg | ||
| 3<br>Sodium Methoxide | 0.8711 kg. | |||
| **Note: The above norms are for regularization and closure purpose only. |
r colorless liquid)||2<br>Methyl Mono Chloro Acetate/<br>Ethyl Chloro Acetate|1.72 kg|| |||3<br>Sodium Methoxide|0.8711 kg.|| |Note: The above norms are for regularization and closure purpose only. No repeat Licence||||| |may be allowed by RA on above norms.||||| |RA concerned may take further necessary action as per above decision of NC.|||||
==> picture [462 x 280] intentionally omitted <==
----- Start of picture text -----<br> Case No. A-14<br>Meeting No. NC/3/MEET/Nov/202324/16<br>Date 09/11/2023<br>Firm’s Name M/s Best Value Chem Private Limited<br>HQ F. No. H QRNORMAPPLY00003244AM23<br>RLA F. No. 34/AX/040/00595/AM23<br>Advance Authorization No. and Date 3411002799 dated 20.09.2022<br>Subject Request of M/s Best Value Chem Private Limited for<br>fixation of ad-hoc norms against Advance Authoristion<br>issued to the firm.<br>Decision: Dr. Dhaval Patel, Technical Expert, Shri Dhruval Parmar (Exim) of the firm had attended the<br>Personal Hearing and explained the case. The Committee heard the explanation of Representative of the firm<br>and after due deliberation the committee has considered for review of ad-hoc norms on the basis of<br>information provided by the firm, it was decided to revise ad-hoc norms as under, or as applied whichever is<br>less: -<br>Export Product Qty. Sl. Import Items Qty. allowed.<br>No.<br> Dimethyl Benzyl Carbinyl Butyrate 1 kg.
rm, it was decided to revise ad-hoc norms as under, or as applied whichever is<br>less: -<br>Export Product Qty. Sl. Import Items Qty. allowed.<br>No.<br> Dimethyl Benzyl Carbinyl Butyrate 1 kg. 1 N Butyric Anhydride 0.80 kg.<br>(1-Cyclohexyl-2-methylpropan-2-yl 2 Magnesium Turning 0.17 kg.<br>butanoate))<br>Note: The above norms are for regularization and closure purpose only. No repeat Licence<br>----- End of picture text -----<br>
may be allowed by RA on above norms.
RA concerned may take further necessary action as per above decision of NC.
| Case No.<br> A-15 | ||||
|---|---|---|---|---|
| MeetingNo.<br>NC/3/MEET/Nov/202324/16 | ||||
| Date<br>09/11/2023 | ||||
| Firm’s Name<br>M/s Best Value Chem Private Limited | ||||
| HQF. No.<br>HQRNORMAPPLY00004468AM23 | ||||
| RLA F. No.<br>34/AX/040/00711/AM23 | ||||
| Advance Authorization No. and Date<br>3411003022dated 18.11.2022 | ||||
| Subject<br>Request of M/s Best Value Chem Private Limited for fixation<br>of ad-hoc norms against Advance Authorisation issued to the<br>firm. | ||||
| **Decision:**Dr. Dhaval Patel, Technical Expert, Shri Dhruval Parmar (Exim)of the firm | had attended the | |||
| Personal Hearing and explained the case. The Committee heard the explanation of Representative of the firm | ||||
| and after due deliberation the committee has considered for review of ad-hoc norms | on the basis of | |||
| information provided by the firm, it was decided to revise | ad-hoc norms as under, or as applied whichever is | |||
| less: - | ||||
| Export Product<br>Qty.<br>Sl.<br>No. | Import Items | Qty. allowed. | ||
| Hexyl Salicylate<br>1 kg.<br>1 | n-Hexanol (Lorol C 6/ Nacol 6) | 0.510 kg. | ||
| (n-Hexyl-ortho-Hydroxy Benzoate)<br>2 | Salicylic Acid | 0.682 kg. | ||
| Note: The above norms are for regularization and closure purpose only. No | repeat Licence | |||
| may be allowed by RA on above norms. | ||||
| RA concerned maytake further necessaryaction asper above decision of NC. |
r regularization and closure purpose only. No**||repeat Licence||| |may be allowed by RA on above norms.||||| |RA concerned maytake further necessaryaction asper above decision of NC.|||||
| Case No.<br> | A-16 |
|---|---|
| MeetingNo. | NC/3/MEET/Nov/202324/16 |
| Date | 09/11/2023 |
| Firm’s Name | M/s Natco Pharma |
| HQ F. No. | HQRNORMREVIW00004490/AM24/DES-III<br>(Earlier F. No. HQRNORMAPPLY00001280/AM23 /DES-III)<br>HQRNORMREVIW00004488AM24/DES-III<br>(Earlier F. No. HQRNORMAPPLY00293027AM22/DES-III) |
| RLA F. No. | 09/AX/040/00174/AM23<br>09/AX/040/00043/AM22 |
| Advance Authorization No. and Date | 0911003150 dated 08.06.2022<br>0911002121dated 21.12.2022 |
| Subject | Request of M/s Natco Pharma for enhancement of quantity of<br>import items in respect of Advance Authorisation issued to<br>them. |
| **Decision:**The Committee considered the | case as per agenda and it has been observed the firm could not |
| attend the PH and requested vide e-mail dated 07/11/2023 has requested to re-schedule the Personal | |
| Hearing after two week. Therefore, the committee has decided to grant the permission for againPersonal | |
| Hearingwith relevant documents/information. |
==> picture [461 x 103] intentionally omitted <==
week. Therefore, the committee has decided to grant the permission for againPersonal|| |Hearingwith relevant documents/information.||
==> picture [461 x 103] intentionally omitted <==
----- Start of picture text -----<br> Case No. A-17<br>Meeting No. NC/3/MEET/Nov/202324/16<br>Date 09/11/2023<br>Firm’s Name M/s Cipla Limited<br>HQ F. No. HQRNORMREVIW00000257/AM24/DES-III<br>(Earlier F. No. HQRNORMAPPLY00396819/AM22/DES-III)<br>RLA F. No. 03/AX/040/01590/AM22<br>Advance Authorization No. and Date 0311013222 dated 22.03.2022<br>----- End of picture text -----<br>
Subject:
Request of M/s Cipla Limited for enhancement of import items against Advance Authorisation issued to the firm.
Decision: The Committee considered the case as per agenda and it was decided to call the firm for attending Personal Hearing before Norms Committee to explain its case along with relevant information / documents.
==> picture [461 x 608] intentionally omitted <==
ed to call the firm for attending Personal Hearing before Norms Committee to explain its case along with relevant information / documents.
==> picture [461 x 608] intentionally omitted <==
----- Start of picture text -----<br> Case No. A-18<br>Meeting No. NC/3/MEET/Nov/202324/16<br>Date 09/11/2023<br>Firm’s Name M/s Royal Pharma<br>HQ F. No. HQRNORMREVIW00000094/AM24/DES-III<br>(Earlier F. No. HQRNORMAPPLY00001359/AM/23)<br>HQRNORMREVIW00000092/AM24/DES-III<br>(Earlier F. No. 01/82/050/01645/AM/19 DES-III)<br>HQRNORMREVIW0005586/AM24/DES-III<br>(Earlier F. No HQRNORMREVIW00000117/AM24/DES-III)<br>F. No. HQRNORMREVIW0005587/AM24/DES-III<br>(Earlier F. No HQRNORMREVIW00000123/AM24/DES-III)<br>F. No. HQRNORMREVIW0005588/AM24/DES-III<br>(Earlier F. No HQRNORMREVIW00000091/AM24/DES-III)<br>HQRNORMREVIW0000006811/AM24/DES-III<br>(Earlier F. No. HQRNORMAPPLY00001742/AM/21)<br>RLA F. No. 03/95/040/00945/AM19<br>03/AX/040/01263/AM23<br>03/95/040/00424/AM18<br>03/95/040/00720/AM19<br>03/95/040/00958/AM15<br>03/95/040/00439/AM21<br>Advance Authorization No. and Date 0311015473 dated 13.06.2022<br>0310825646 dated 13.12.2018<br>0310793866 dated 12.02.2015<br>0310815337 dated 23.08.2017<br>0310824487 dated 17.10.2018<br>0310838908 dated 15.10.2020<br>Subject Request of M/s Royal Pharma for enhancement in the<br>quantity of import item in respect of adhoc norms fixed<br>against Advance Authorizations issued to the firm.<br>Decision: Shri Padmakant Pandya, Manager (Exports), Shri Rutvij Purohit, Asstt. Manager (Exports)<br>and Shri P.J.
spect of adhoc norms fixed<br>against Advance Authorizations issued to the firm.<br>Decision: Shri Padmakant Pandya, Manager (Exports), Shri Rutvij Purohit, Asstt. Manager (Exports)<br>and Shri P.J. Gandhi, Technical Consultant of the firm had attended the Personal Hearing and explained the<br>case. The Committee heard the explanation of Representative of the firm and after due deliberation the<br>committee has considered for review of ad-hoc norms on the basis of information provided by the firm, it was<br>decided to revise ad-hoc norms as under, or as applied whichever is less: -<br>Export Product Qty. Sl. No. Import Items Qty.<br>allowed.<br>BICALUTAMIDE SULFIDE 1 kg. 1 N-[4-CYANO-3- (TRIFLUORO 0.750 kg.<br>CHEMICAL NAME: N-[4-CYANO-3- METHYL)PHENYL]<br>(TRIFLUORO METHYL)PHENYL]- METHACRYLAMIDE<br>3-[(4-FLUOROPHENYL THIO)] -2- MATERIAL FORMULA<br>HYDROXY-2-METHYL C12H9ON2F3 AND<br>PROPIONALIDE MATERIAL WEIGHT 254<br>2 4-FLUOROTHIOPHENOL 0.344 kg.<br>MATERIAL FORMULA<br>C6H5F5 AND MATERIAL<br>WEIGHT 128<br>RA concerned may take further necessary action as per above decision of NC.<br>----- End of picture text -----<br>
ENOL 0.344 kg.<br>MATERIAL FORMULA<br>C6H5F5 AND MATERIAL<br>WEIGHT 128<br>RA concerned may take further necessary action as per above decision of NC.<br>----- End of picture text -----<br>
| Case No.<br> | A-19 |
| MeetingNo. | NC/3/MEET/Nov/202324/16 |
| Date | 09/11/2023 |
| Firm’s Name | M/s Panacea Biotec Pharma Limited |
| HQ F. No. | HQRNORMREVIW00005946/AM24/DES-III<br>(EarlierF.No. HQRNORMAPPLY00004468AM23) |
| RLA F. No. | 05/AX/040/00321/AM22 |
| Advance Authorization No. and Date | 0511007823 dated 11.01.2022 |
| Subject | Request of M/s Panacea Biotec Pharma Limitedfor fixation of<br>ad-hoc norms against Advance Authorisation issued to the<br>firm. |
| **Decision:**The Committee considered the case as per agenda and it has been observed the firm could not | |
| attend the PH and requested vide e-mail dated 07/11/2023 has requested to re-schedule the Personal | |
| Hearing after two weeks. Therefore, the committee has decided to grant the permission for againPersonal | |
| Hearingwith relevant documents/information. |
==> picture [461 x 364] intentionally omitted <==
eeks. Therefore, the committee has decided to grant the permission for againPersonal|| |Hearingwith relevant documents/information.||
==> picture [461 x 364] intentionally omitted <==
----- Start of picture text -----<br> Case No. A-20<br>Meeting No. NC/3/MEET/Nov/202324/16<br>Date 09/11/2023<br>Firm’s Name M/s Matrix Life Science Private Limited<br>HQ F. No. HQRNORMAPPLY00401252AM22<br>RLA F. No. 03/AX/040/01906/AM22<br>Advance Authorization No. and Date 0311013320 dated 25.03.2022<br>Subject Request of M/s Matrix Life Science Private Limited for<br>fixation of ad-hoc norms against Advance Authorisation<br>issued to the firm.<br>Decision : Shri Kunal Sikchi, Director and Shri Nitin Vyas, Sr. Executive of the firm had attended the<br>Personal Hearing and explained firm’s case. The Committee heard the explanation of Representative of the<br>firm and after due deliberation the committee has considered for fixation of ad-hoc norms as per agenda and<br>taking cue from the earlier decision for same export product/import product in meeting<br>No.NC/3/MEET/Oct/202122/9 dated 15/10/2021 against advance authorization No. 0310837496dated<br>30/07/2020 , it was decided to fix ad-hoc norms under Para 4.07 of HBP Vol. I as per details given below or as<br>applied by the firm, whichever is less:-<br>Sl. No. Export Product Qty.<br>1 62/0- Phytosterol Natural Refined Phytosterol 95% 120000.000 kg.<br>2 62/0- Natural Mixed Tocopherol 70% 55000.000 kg.<br>Sl. No.
the firm, whichever is less:-<br>Sl. No. Export Product Qty.<br>1 62/0- Phytosterol Natural Refined Phytosterol 95% 120000.000 kg.<br>2 62/0- Natural Mixed Tocopherol 70% 55000.000 kg.<br>Sl. No. Import Item Qty.<br>1 Fatty Acid Distillate / Deoderised Distillate 1842500 kg.<br>2 Acetone 88000 kg.<br>3 N-HEPTANE 188100 kg.<br>RA concerned may take further necessary action as per above decision of NC.<br>----- End of picture text -----<br>
| CaseNo. | A-21 |
|---|---|
| MeetingNo. | NC/3/MEET/Nov/202324/16 |
| Date | 09/11/2023 |
| Firm’s Name | M/s Matrix Life Sciences Private Limited |
| HQ F. No. | F. No.HQRNORMREVIW00006377/AM24/DES-III<br>(EarlierF.No. 01/82/050/02017/AM19 /DES-III)<br>F. No.HQRNORMREVIW00006376/AM24/DES-III<br>(EarlierF.No. 01/82/050/00798/AM19 /DES-III) |
==> picture [461 x 537] intentionally omitted <==
----- Start of picture text -----<br> F. No. HQRNORMREVIW00006375/AM24/DES-III<br>(Earlier F. No. 01/82/050/01151/AM18 /DES-III)<br>F. No. HQRNORMREVIW00006374/AM24/DES-III<br>(Earlier F. No. 01/82/050/00552/AM18 /DES-III)<br>F. No. HQRNORMREVIW00006373/AM24/DES-III<br>(Earlier F. No. 01/82/050/265AM18 /DES-III)<br>F. No. HQRNORMREVIW00006372/AM24/DES-III<br>(Earlier F. No. 01/82/050/544AM17 /DES-III)<br>RLA F. No. 08/24/040/00304/AM17<br>03/95/040/00999/AM17<br>03/95/040/00267/AM18<br>03/95/040/00651/AM18<br>03/95/040/00037/AM19<br>03/95/040/00488/AM19<br>Advance Authorization No.
M17 /DES-III)<br>RLA F. No. 08/24/040/00304/AM17<br>03/95/040/00999/AM17<br>03/95/040/00267/AM18<br>03/95/040/00651/AM18<br>03/95/040/00037/AM19<br>03/95/040/00488/AM19<br>Advance Authorization No. and Date 0310824019 dated 26.09.2018<br>0310820676 dated 26.04.2018<br>0310817413 dated 29.11.2017<br>0310814547 dated 11.07.2017<br>0310812435 dated 11.04.2017<br>0310806238 dated 14.07.2016<br>Subject Request of M/s Matrix Life Sciences Private Limited for<br>enhancement in the quantity of import item in respect of<br>ad-hoc norms fixed against Advance Authorization No.<br>0310824019 dated 26.09.2018, 0310820676 dated<br>26.04.2018, 0310817413 dated 29.11.2017, 0310814547<br>dated 11.07.2017, 0310812435 dated 11.04.2017 &<br>0310806238 dated 14.07.2016<br>Decision: Shri Kunal Sikchi, Director and Shri Nitin Vyas,Sr. Executive of the firm had attended the Personal<br>Hearing and explained firm’s case. The Committee heard the explanation of Representative of the firm and<br>after due deliberation the committee has considered for review of ad-hoc norms on the basis of information<br>provided by the firm, it was decided to revise ad-hoc norms as under, or as applied whichever is less:-<br>Export Product Qty. Sl. Import Items Qty.<br>No. allowed.<br> D Alpha Tocopherol having Net content 1 kg. 1 Fatty Acid Distillate 30.00 kg.<br>of Fatty Acid Distillate/Deoderised Deoderised Distillate<br>Distillate 727000.00 kgs. Methenol 99 2 Methenol 99% 9.18 kg.<br>Percent 222400.00 kg. S Heptane 71200.00 3 S-Heptane 2.94 kg.<br>kg.
atty Acid Distillate/Deoderised Deoderised Distillate<br>Distillate 727000.00 kgs. Methenol 99 2 Methenol 99% 9.18 kg.<br>Percent 222400.00 kg. S Heptane 71200.00 3 S-Heptane 2.94 kg.<br>kg. Acetone 29000.00 kg.<br>4 Acetone 1.20 kg.<br>Note:The above norms are for regularization and closure purpose only. No repeat Licence may be<br>allowed by RA on above norms.<br>RA concerned may take further necessary action as per above decision of NC.<br>----- End of picture text -----<br>
| Case No.<br> | A-22 |
|---|---|
| MeetingNo. | NC/3/MEET/Nov/202324/16 |
| Date | 09/11/2023 |
| Firm’s Name | M/s Dhanuka Laboratories Limited |
| HQF. No. | HQRNORMAPPLY00007254AM23 |
| RLA F. No. | 05/AX/040/03629/AM23 |
| Advance Authorization No. and Date | 0511018016 dated 28.03.2023 |
| Subject | Request of M/s Dhanuka Laboratories Limitedfor inclusion of<br>raw material OTBN in import item. |
| **Decision:**Shri Subhash Sharma, DGM (Commercial) and others representative of the firm had attended the | |
| Personal Hearing and explained firm’s case. The Committee heard the explanation of Representative of the | |
| firm and after due deliberation the committee has considered for review of ad-hoc norms on the basis of | |
| informationprovided bythe firm,it was decided to revise ad-hoc norms as under,or as applied whichever is |
less:-
==> picture [433 x 120] intentionally omitted <==
norms on the basis of|| |informationprovided bythe firm,it was decided to revise ad-hoc norms as under,or as applied whichever is||
less:-
==> picture [433 x 120] intentionally omitted <==
----- Start of picture text -----<br> Export Product Qty. Sl. Import Items Qty. allowed.<br>No.<br>TELMISARTAN CRUDE 1 kg. 1 2-n-propyl-4-methyl-6-(1- 0.57 kg.<br>(POWDER) methylbenzimidazol-2-yl)<br>2 2-Cyano-4-Methyl Biphenyl (OTBN) 0.65 kg.<br>3 Acetic Acid 0.824 kg.<br>4 Toluene 1.57 kg.<br>5 Methylene Chloride 1.83 kg.<br>6 Methanol 1.83 kg.<br>----- End of picture text -----<br>
RA concerned may take further necessary action as per above decision of NC.
==> picture [461 x 126] intentionally omitted <==
----- Start of picture text -----<br> Case No. A-23<br>Meeting No. NC/3/MEET/Nov/202324/16<br>Date 09/11/2023<br>Firm’s Name M/s Dhanuka Laboratories Limited<br>HQ F. No. HQRNORMAPPLY00003036AM23<br>RLA F. No. 34/AX/040/01577/AM23<br>Advance Authorization No. and Date 0511014727 dated 09.09.2022<br>Subject Request of M/s Dhanuka Laboratories Limited for<br>enhancement of ad-hoc norms in the Advance Authorisation<br>issued to the firm.<br>----- End of picture text -----<br>
.2022<br>Subject Request of M/s Dhanuka Laboratories Limited for<br>enhancement of ad-hoc norms in the Advance Authorisation<br>issued to the firm.<br>----- End of picture text -----<br>
| Export Product | Qty. | Sl.<br>No. | Import Items | Qty.<br>allowed. |
|---|---|---|---|---|
| 7ANCA/ ANHA (7-Amino-3-Nor-<br>3-Cephem-4-Carboxylic<br>Acid)<br>(7ANCA/7ANHA /Powder) | 1 kg. | 1 | Pencillin G Potassium First Crystal | 9.63 kg. |
| 2 | METHYLENE CHLORIDE<br>/Dichloromethane | 38.54 kg. | ||
| 3 | Morpholine | 2.158 kg. | ||
| 4 | Triethylamine | 1.50 kg. | ||
| 5 | Methanol | 21.24 kg. | ||
| 6 | Methane Sulphonyl Chloride | 1.59 kg. | ||
| 7 | Activated carbon | 0.100 kg. | ||
| 8 | Acetone | 2.38 kg. | ||
| 9 | Acetic Acid | 8.63 kg. | ||
| concerned maytake further necessaryaction as | per above decision of NC. |
Verbatim extracted text (OCR/PDF). Older scans and tables may show extraction artifacts — verify against the original for anything you act on.
No analysis generated for this document yet (analysis runs over brief docs + on-demand). Run build_analysis.py --ids 8036 --apply.